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Bovine leukemia virus (BLV) tax is an essential gene
involved in the transcriptional activation of viral ex-
pression. Tax is also believed to be implicated in leuke-
mogenesis because of its ability to immortalize primary
cells in vitro. To gain insight into the molecular path-
ways mediating the activities of this important gene, we
identified cellular proteins interacting with Tax. By
means of a two-hybrid approach, we show that Tax spe-
cifically interacts with MSX2, a general repressor of
gene expression. GST pull-down experiments and co-
immunoprecipitation assays further confirmed binding
specificity. Furthermore, the N-terminal residues 1–79
of MSX2 are required for binding, whereas the C-termi-
nal residues 201–267 of MSX2 do not play a critical role.
Whereas the oncogenic potential of Tax in primary cells
was only slightly affected by overexpression of MSX2,
the other function of Tax, namely LTR-dependent tran-
scriptional activation, was inhibited by MSX2 in human
HeLa and bovine B-lymphoblastoid (BL3) cell lines. This
MSX2 repression function can be counteracted by over-
expression of transcription factors CREB2 and RAP74.
The Tax/MSX2 interplay thus results in repression of
viral transcriptional activation possibly acting as a reg-
ulatory feedback loop. Importantly, this viral gene si-
lencing is not strictly associated with a concomitant loss
of Tax oncogenicity as measured by its ability to immor-
talize primary cells. And interestingly, MSX2 also inter-
acts with and inhibits the transactivation function of
the related Tax1 protein encoded by the Human T-cell
leukemia virus type 1 (HTLV-1).
Human T-cell leukemia virus type 1 (HTLV-1)1 and bovine
leukemia virus (BLV) are members of the Deltaretrovirus ge-
nus in the Retroviridae family (1–4). In addition to the struc-
tural proteins Gag, Pol, and Env, these viruses also encode a
series of regulatory proteins: Tax, Rex, p12/R3, and p13/G4.
The Tax protein is a transcriptional activator, which increases
the synthesis of viral proteins acting on a triplicate 21-bp
element located in the 5 long terminal repeat (LTR) (5–7). Tax
does not interact directly with DNA but rather acts via cellular
factors, such as members of the CREB/ATF family of basic
leucine zipper proteins (8–11). The tax gene is believed to be
essential because its presence is absolutely required for infec-
tivity in vivo (12). Besides its role in the regulation of tran-
scription, the Tax protein also exhibits an oncogenic potential
(13). Tax behaves as an immortalizing oncogene because it is
able to cooperate with the Ha-ras oncoprotein to fully trans-
form primary rat embryo fibroblasts (14, 15). Both transacti-
vation and immortalizing functions of Tax can be dissociated by
mutations in specific regions of the protein. For example, mu-
tation of the phosphorylation sites at serines 106 and 293 of
BLV Tax abrogates immortalization potential in vitro but
maintains transcriptional activity and viral oncogenicity in
vivo (16, 17). Conversely, the transactivation of the LTR pro-
moter is not required for Tax to transform primary cells in vitro
(14). The Tax protein of HTLV-1 (Tax1) is known to activate
several cellular genes including IL-2, IL-2R, IL-3, TNF-, and
GM-CSF (18–20). Tax1 is also involved in cell cycle regulation
by direct activation of cyclin D3 and cyclin kinases cdk4 and
cdk6 (21), or by inactivating the cyclin-dependent kinase inhib-
itor p16INK4A (22). In fact, protein-protein interactions with
cellular factors are crucial for Tax1 to perturb the regulation of
many cellular pathways (23). These HTLV-1 Tax binding fac-
tors include the human mitotic checkpoint protein HsMAD1
(24), MEKK1 (25), the IB kinase (26), or the PCAF protein
(27). In contrast, little is known about the cellular partners of
the BLV Tax protein. In this study, we describe a functional
interaction between the homeobox protein MSX2 and the BLV
Tax oncoprotein.
EXPERIMENTAL PROCEDURES
Plasmids—Plasmids pSGMSX2 and pEGFPMSX2 were constructed
by subcloning the human MSX2-cDNA (kindly offered by Dr. T. Iimura,
Tokyo Medical and Dental University, Japan) into pSG5 (Stratagene)
and pEGFP-C1 (Clontech), respectively. Plasmids pcDNAMSX2-c-Myc,
pcDNAMSX2N-c-Myc, and pcDNAMSX2C-c-Myc, which express re-
spectively, C-terminal c-Myc-tagged full-length, amino acids 80–267
and amino acids 1–200 of the human MSX-2 protein, were constructed
by inserting the human MSX2 cDNA, or PCR-derived MSX2 trun-
cation mutants into pcDNA3.1/myc-HisB (Invitrogen). Plasmid
pcDNARAP74-flag was obtained by subcloning the human RAP74
cDNA (kindly offered by Dr. Z. Burton, Michigan State University) into
pcDNA3.1Flag (Invitrogen).
The pLTRLuc, pLTR1Luc, and pCMVLuc reporter constructs con-
tain, respectively, the BLV LTR, the HTLV-1 LTR, and the cytomega-
lovirus (CMV) promoter upstream of the firefly luciferase gene. Vectors
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pSGTax and pSGTax1 express the BLV and the HTLV-1 Tax proteins
under the control of the SV40 promoter. Plasmid pCMVTax, provided
by E. Wattel (Centre Le´on Be´rard, Lyon, France), is a mammalian
expression vector for HTLV-1 Tax. Plasmids pSGCREB and pPKA
express, respectively, the bovine CREB2 protein and the protein kinase
A (28). Plasmids pBDTax, pBDTax(106  293), p53, and pLaminC
express the DNA binding domain (BD) of the yeast transactivator Gal4
fused to the BLV Tax protein, the Tax mutant in which serine residues
106 and 293 were replaced by alanine sequences (16), the murine p53
(amino acids 72–390), and the human Lamin C (amino acids 67–230),
respectively. Plasmids pADMSX2 and pSV40 code for the Gal4-activat-
ing domain (AD) fused to the human MSX2 protein or the amino acids
84–708 of the SV40 large T-antigen, respectively. Vector pGexTax codes
for a fusion protein between Tax and the glutathione S-transferase
(GST) (29).
-Galactosidase Assay—Yeast cells were co-transformed with
pADMSX2 and pBDTax plasmids and grown overnight in synthetic
dropout medium (S.D.) lacking uracil, leucine, tryptophan, and histi-
dine (Ura-Leu-Trp-His-) but supplemented with 2 mM 3-aminotriazole
(3AT). Cells were then diluted 5-fold in YPAD-rich medium (1% bacto-
yeast extract, 2% bacto-peptone, 2% glucose, and 0.6% adenine) and
cultivated until the absorbance at 600 nm (A600) reached 0.5–0.8. After
a wash in Z buffer (60 mMNa2HPO4, 40 mMNaH2PO4, 10 mM KCl, 1 mM
Mg2SO4), yeast were lysed by three freeze-thaw cycles in liquid nitro-
gen. Cell lysates were then resuspended in 0.7 ml of Z buffer containing
0.27% -mercaptoethanol and 160 l of ortho-nitrophenyl--D-galacto-
pyranoside (ONPG) 4 mg/ml in Z buffer, as a substrate of -galactosid-
ase. After incubation at 30 °C, the reactions were stopped by addition of
400 l of 1 M Na2CO3, and the A420 was determined. -Galactosidase
activity was calculated using the following equation: -galactosidase
units  1000  (A420/t  V  A600) where t  time (min) of incubation
and V  volume (ml) of culture.
GST Pull-down Assay—The HB101 strain of Escherichia coli was
transformed with plasmid pGexTax or, as a control, pGex-2T. Over-
night cultures were 6 diluted in fresh NZY medium (21 g/liter) (In-
vitrogen) containing 100 g/ml ampicillin and incubated until the A600
reached 0.7. After induction with 1 mM of isopropyl--D-thiogalactoside
(IPTG), bacteria were allowed to grow for an additional 3 h. After
harvesting and washing with PBS (1 mM KH2PO4, 150 mM NaCl, 3 mM
Na2HPO4 pH 7.4), bacteria were lysed by sonication and by incubation
at 4 °C in the presence of 1% Triton X-100. After centrifugation at
10,000  g for 15 min at 4 °C, the supernatant was mixed with gluta-
thione-Sepharose beads (Amersham Biosciences) over 1 h at 4 °C. Fi-
nally, the beads were washed four times with PBS and stored at 4 °C as
a 15% suspension in the presence of a mixture of protein inhibitors
(Complete, Roche Applied Sciences). The GST-Tax, or GST polypeptides
bound to the beads were quantified using the Bradford method (Bio-Rad
assay). For the pull-down assay, equal amounts of fusion proteins were
added to 5 l of rabbit reticulocyte lysates (TNT in vitro transcription-
translation, Promega) programmed with pcDNAMSX2-c-Myc,
pcDNAMSX2N-c-Myc, pcDNAMSX2C-c-Myc, or pSGMSX1 plasmids
in the presence of a mixture of [35S]methionine and [35S]cysteine (Pro-
mix, Amersham Biosciences). After gentle shaking for 3 h at 4 °C in
NETN binding buffer (200 mMNaCl, 20 mM Tris-HCl pH 8, 1 mM EDTA,
and 0.5% Nonidet P-40), the beads were washed four times in binding
buffer. Bound proteins were eluted in SDS sample buffer, resolved by
12.5% SDS-PAGE, soaked in amplifying solution (Enlightning,
PerkinElmer Life Sciences), and visualized by autoradiography.
Co-immunoprecipitation—HeLa cells were cultivated at 37 °C in 5%
CO2/air-humidified atmosphere in minimum essential medium (MEM)
with L-glutamine (Invitrogen) supplemented with 10% fetal calf serum,
100 units of penicillin/ml, 100 g/ml of streptomycin, and 1 mM sodium
pyruvate. One day before transfection, the cells were divided and
seeded in 6-well plates at a density of 3  105 cells per well. The cells
were next transfected with 2 g of plasmid DNA using the Lipo-
fectamine reagent (Invitrogen) as described by the manufacturer.
Thirty hours after transfection, the cells were washed in PBS buffer,
scraped, and lysed in NET buffer (150 mM NaCl, 50 mM Tris-HCl, pH
8.5 mM EDTA, 0.5% Nonidet P-40, and 0.25% sodium deoxycholate)
containing protease inhibitors (Complete).
The lysates were immunoprecipitated with an anti-GFP antibody
(Molecular Probes), or a preimmune antiserum coupled with protein
A-Sepharose beads (Amersham Biosciences). The immunoprecipitates
were washed three times in NET buffer and once in TNE (10 mM
Tris-HCl, pH 8.3, 150 mM NaCl, and 1 mM EDTA) and electrophoresed
on a denaturing 12.5% polyacrylamide gel (SDS-PAGE). After transfer
of the proteins onto polyvinylidene difluoride, the membranes were
saturated in 1% Blocking Reagent (Roche Applied Science), incubated
overnight with anti-Tax (5A5) antibody, washed in TBST (50 mM Tris-
HCl pH 7.5, 150 mM NaCl, and 0.1% Tween 20), and revealed by
chemiluminescence using horseradish peroxidase-conjugated anti-
mouse immunoglobulin antibody.
Immunoprecipitations were also performed under similar experi-
mental conditions using reticulocytes lysates programmed with pSG-
Tax1 and pcDNAMSX2-c-Myc. Anti-Tax1 (Tax3, provided by F. Bex,
Universite´ Libre de Bruxelles) and anti-c-Myc (A-14, Santa Cruz Bio-
technology) monoclonal antibodies were used for immunoprecipitation
and Western blot experiments, respectively.
Confocal Microscopy—Two micrograms of plasmids (pSGTax,
pcDNAMSX2-c-Myc, and pSGTaxpcDNAMSX2-c-Myc) were trans-
fected into HeLa cells using Genejammer (Stratagene). Twenty-four
hours post-transfection, cells were fixed in 3.7% formaldehyde (20 min
at 4 °C), permeabilized with 0.1% Nonidet P40 (10 min), incubated with
anti-c-Myc (A-14, Santa Cruz Biotechnology) and anti-Tax antibody
(5A5), and then with fluorescein (FITC) or Alexa 546-coupled anti-
rabbit or anti-mouse immunoglobulin conjugates (Molecular Probes).
After nuclear staining with TOPRO-3 and fixation with mounting me-
dium (Prolong Antifade kit, Molecular Probes), the cells were analyzed
using a Zeiss fluorescence confocal microscope (Axiovert 200 with
LSM 510).
Luciferase Assays—One microgram of reporter plasmids pLTRLuc,
pLTR1Luc, or pCMVLuc and different amounts of effector vectors
(pSGTax, pCMVTax, pSGCREB, pPKA, pcDNARAP74-flag,
pcDNAMSX2-c-Myc, pcDNAMSX2N-c-Myc, pcDNAMSX2C-c-Myc,
pSGMSX1, and pSGMSX2) were transfected into 3  105 HeLa cells
using Genejammer, 8  105 BL3, or Jurkat cells using TransIT-
Jurkat (Mirus Bio). Twenty-four hours post-transfection, cells were
washed three times with PBS, lysed, and luciferase activities were
determined using the Promega luciferase assay kit according to the
manufacturer’s instructions.
Primary Rat Embryo Fibroblasts (REFs) Transformation Assay—
REFs were transfected with 2 g of plasmids (pSGTax, pSGMSX2,
pSV2NeoEJ, pSV2Myc, see Ref. 13) using Effectene reagent (Qiagen) as
described by the manufacturer. Forty-eight hours post-transfection,
cells were collected, washed with PBS, and either cultured in the
presence of 400 g of G418 per ml to score for foci formation, or injected
subcutaneously into thymus-less nude mice. A total of six mice in three
independent experiments were injected for each plasmid combination.
The tumor volume was calculated by the ellipsoid formula: 4/3ab2
where a and b are the length and width of the tumor, respectively.
RESULTS
Identification of MSX2 as a Ligand for Tax—Out of a yeast
two-hybrid screen, we previously isolated several clones inter-
acting with BLV Tax (29) among which three of them corre-
sponded to the homeodomain protein MSX2. To confirm the
interactions of this primary screen, expression vectors for both
partners were extracted and retransformed into yeast. The
different clones were then tested for their ability to specifically
activate a -galactosidase reporter construct that can be in-
duced only in the presence of both partners. As shown in Table
I, yeast transfected with pBDTax and pADMSX2 were able to
form colonies () and expressed the -galactosidase enzyme
(20 units). In contrast, yeast containing MSX2p53 or
MSX2Lamin C failed to grow (Table I, ) whereas
those expressing only the Tax protein formed small colonies
TABLE I
Tax interacts with MSX2 in yeast
The PJ696 yeast strain was transformed with indicated plasmids as
described under “Experimental Procedures.” Cell colony viability was
evaluated: dead (), efficiently growing (), or forming very small
colonies (*). The strengths of the interactions were next measured by
titration of the -galactosidase units (ONPG assay). Values indicated
are the means and S.D. of three independent experiments.
Vectors Growth -Gal units
pBDTax  pADMSX2  20  5
pBDTax(106  293)  pADMSX2  18  4
pBDTax * 3  2
p53  pADMSX2  
pLaminC  pADMSX2  
p53  pSV40  36  8
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(Table I, *) with a background enzymatic activity of 3 units. It
thus appears that Tax, when bound to DNA, can generate weak
but significant basal transcriptional activation of the reporter
gene. As a positive control, yeast transformed by p53 and
pSV40 expressed high levels of -galactosidase (36 units). We
conclude that BLV Tax specifically binds to MSX2 in yeast.
Tax and MSX2 Interact in Vitro and Coimmunoprecipitate in
Cell Lysates—To assess the specificity of the interaction be-
tween BLV Tax and MSX2 in vitro, we performed GST pull-
down experiments. To this end, BLV Tax protein was expressed
as a fusion protein with GST using the pGexTax vector. On the
other hand, MSX2, truncated mutants MSX2N (lacking resi-
dues 1–79 of MSX2) and MSX2C (lacking residues 201–267 of
MSX2) and MSX1 (which has 51% identity with MSX2 in their
N-terminal regions and 62% identity in their C-terminal re-
gions) were synthesized in rabbit reticulocyte lysates in the
presence of 35S-labeled methionine and cysteine (Fig. 1A). The
lysates containing the labeled MSX proteins were incubated
with GST-Tax fusion protein bound to glutathione-Sepharose
beads. The beads were then washed extensively in binding
buffer, and the bound polypeptides subjected to SDS-PAGE
analysis (Fig. 1B). MSX2, and its C-terminal-deleted mutant
(MSX2C) specifically bound to GST-Tax fusion protein but did
not interact with GST alone. Under the same experimental
conditions, MSX1 and MSX2N mutant did not interact with
GST-Tax (Fig. 1B). We conclude that BLV Tax binds to MSX2
in vitro, and that the N-terminal domain of MSX2 is required
for the interaction.
To test whether BLV Tax andMSX2 interact in cell lysates, we
first immunoprecipitated the MSX2 protein, and the presence of
Tax in the complex was subsequently assessed by Western blot.
For this purpose, two vectors pEGFPMSX2 (expressing a fusion
protein between MSX2 and the green fluorescent protein) and
pSGTax were transfected in HeLa cells and cultivated over 30 h.
After cell lysis, proteins were immunoprecipitated using either
rabbit anti-GFP or with a control rabbit antiserum (Fig. 1C). The
immunoprecipitates were analyzed by SDS-PAGE, transferred
onto a nylon membrane, and revealed with two Tax-specific
monoclonal antibodies (5A5 and 6A7). A polypeptide of 34 kDa
sharing antigenicity and co-migrating with the Tax protein (lane
1) was revealed in immunoprecipitates from lysates containing
GFPMSX2 (lane 5) but not GFP alone (lane 4). As controls for
specificity, Tax was not revealed when the cells were transfected
with a control plasmid (lanes 2 and 3) or when the GFP antibody
was omitted (lanes 7–10). It thus appears that Tax and MSX2
interact in HeLa cell lysates providing additional evidence for the
specificity of their interaction.
Colocalization of Tax and MSX2—To assess the subcellular
localization of Tax and MSX2 in mammalian cells we performed
confocal microscopy. As demonstrated previously, MSX2 protein
fused to GFP localizes mainly in the cell nucleus (29). To confirm
and extend these observations, the MSX2 protein was tagged
with the c-Myc epitope (in plasmid pcDNAMSX2-c-Myc). HeLa
cells were transfected with this expression vector together with
pSGTax coding for BLV Tax. Twenty-four hours post-transfec-
tion, cells were fixed, permeabilized, and incubated with antibod-
ies against BLV Tax (5A5) and c-Myc (A-14). Finally, anti-Tax
and anti-cMyc antibodies were revealed by Alexa-546- and FITC-
coupled conjugates, respectively.
BLV Tax was localized in the nucleus (stained by TOPRO-3)
as well as in the cytoplasm of the transfected cells, as revealed
by the orange (Alexa 546) and red (TOPRO-3) fluorochrome
profiles, two types of patterns were observed (Fig. 2, Tax). In
contrast, MSX2-c-Myc protein was localized exclusively in the
nucleus of HeLa cells (Fig. 2, MSX2). Tax and MSX2 co-local-
ized in the nucleus, as revealed by the yellow color of the
merged green and orange fluorochromes (Fig. 2, TaxMSX2)
and the perfect match of the profiles of the green and orange
fluorochrome intensities (Supplemental Fig. 3). In addition, in
TaxMSX2 double positive cells, Tax was almost exclusively
FIG. 1. BLV Tax interacts with MSX2. A, MSX2, MSX2N, MSX2C, and MSX1 proteins were synthesized using rabbit reticulocyte lysates
in the presence of 35S-labeled methionine and cysteine. Five microliters of the programmed lysates were then electrophoresed in a 12.5%
SDS-PAGE gel, dried, and exposed to x-ray film. B, five microliters of lysates containing MSX2, MSX2N, MSX2C, or MSX1 were mixed with
GST-Tax or GST protein bound to glutathione-Sepharose beads. The mixtures were incubated 3 h at 4 °C, washed extensively, and electrophoresed
onto a 12.5% SDS-PAGE gel. [35S]methionine-labeled MSX2 protein was then revealed by autoradiography. C, HeLa cells were co-transfected with
plasmid pEGFPMSX2 expressing the GFPMSX2 protein and plasmids pSGTax for the BLV Tax protein. After 30 h, cells were lysed, and
immunoprecipitation (IP) was then performed using rabbit anti-GFP antibody or, as control a rabbit antiserum (Control IgG). After extensive
washes, the immunoprecipitates were used in Western blotting experiment using a mouse anti-Tax antibody (5A5). As negative controls, the same
experiments were performed in parallel using lysates from HeLa cells transfected with pEGFPpSGTax, pEGFP, and pEGFPMSX2. The amount
of transfected DNA was maintained constant with plasmid pSG5.
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concentrated in the nucleus (orange arrows). In contrast, in the
absence of MSX2 (e.g. single Tax transfectants), Tax was also
cytoplasmic (see yellow arrows). We conclude that the Tax
subcellular distribution appears to be altered in the presence
of MSX2.
MSX2 Does Not Interfere with the Tax-immortalizing Func-
tion in Vitro—The Tax protein exhibits an oncogenic potential
in cell culture (13). Indeed, Tax cooperates with Ha-ras onco-
gene to transform primary REFs that are then capable of
inducing tumors in nude mice (13, 15). Interestingly, a trans-
dominant mutant of MSX2 has been shown to interfere with
cell proliferation and transformation (30–32). To address the
role of BLV Tax/MSX2 interaction in cell transformation, vec-
tors expressing Tax and MSX2 (pSGTax and pSGMSX2) were
co-transfected with the Ha-ras oncogene in REF cells. Three
days post-transfection, cells were harvested and half of them
cultured in the presence of G418 to select for stable transfec-
tants. Cells co-expressing Tax and Ha-ras oncogenes form
transformed colonies (foci) that can be counted from the culture
media (Table II, Cell culture). The other collected cells were
directly injected into nude mice, and the tumor volumes were
determined 1 month post-injection (Table II). As a positive
control for the REF transformation assay, co-expression of Myc
and Ras induced formation of numerous foci (50 foci) and gen-
erated large tumors in nude mice (5000–7000 mm3). As a
negative control, REF cells co-transfected by Ras and an empty
vector (pSG5) yielded only background levels. As expected,
co-expression of Tax and Ras induced REF transformation (22
foci and tumors of 900–3000 mm3), confirming our previous
results (13). In contrast, MSX2 by itself is not tumorigenic in
this system (0 foci and tumor volume 	 300 mm3) further
confirming and extending previous observations in NIH3T3
cells (32). Most importantly, co-transfection of MSX2 did not
affect Tax transformation capacity (25 foci) although the tumor
volume was slightly reduced (400–900 mm3 versus 900–3000
mm3). From these transformation assays, we conclude that
MSX2 does not abrogate the ability of Tax to immortalize
primary REF cells.
MSX2 Represses BLV Tax Transactivation—MSX2 is a gen-
eral repressor of gene expression interacting with components
of the basal transcriptional machinery, such as TFIIF (33).
Indeed, MSX2 has been shown to inhibit the expression under
the control of several promoters including the osteocalcin pro-
moter (34, 35) and the SV40 promoter (36). Because MSX2
binds to Tax, we examined whether MSX2 could interfere with
transcriptional activation of the viral LTR promoter. Therefore,
we co-transfected HeLa cells with expression vectors for Tax
(pSGTax) and MSX2 (pSGMSX2) together with the pLTRLuc
reporter construct. This latter plasmid contains the BLV pro-
moter cloned upstream of the firefly luciferase gene. Twenty-
four hours post-transfection, the cells were harvested, and the
luciferase activities were measured in the lysates. It appeared
that, luciferase activity was gradually decreased by MSX2 in a
dose-dependent manner (Fig. 3A). As illustrated for BLV Tax
by a Western blot in B, inhibition of transactivation was not
because of a decrease in the levels of Tax. We conclude that
MSX2 very efficiently represses Tax transactivation of the LTR
promoter. As expected, MSX2 also inhibited, but to a lesser
extent, the cytomegalovirus promoter (Fig. 3C, CMV-Luc) fur-
ther confirming the role of MSX2 as a general inhibitor of
transcription. Because BLV infects B-lymphocytes, we per-
formed similar transfection experiments using the bovine B-
lymphoblastoid cell line (BL3). It appeared that MSX2 also
inhibited Tax-dependent transactivation in BL3 cells (Fig. 3D).
Together, these data demonstrate that Tax-dependent LTR
transactivation activity is also inhibited by the homeodomain
protein MSX2, similar to many cellular and viral promoters.
Neither MSX1 nor the MSX2N mutant unable to bind Tax
(Fig. 1B) inhibited the Tax transactivation function, confirming
the specificity of the MSX2 repression of Tax-dependent LTR
transactivation (Fig. 3E).
Transcription Factors CREB2 and RAP74 Interfere with
MSX2-dependent Repression of Tax Transactivation—To acti-
vate viral transcription, the Tax protein requires a 21-bp se-
quence (Tax-responsive element), which is repeated three
times within the LTR (7, 37). These repeats share a motif
resembling the cyclic AMP (cAMP)-responsive element (CRE)
core sequence (TGACGTCA) (38). Tax does not bind directly to
these motifs but interacts with CREB/ATF cellular transcrip-
tion factors (8, 9). Among these, CREB2 induces LTR-depend-
ent activation in the presence of PKA and activates Tax-di-
rected transactivation (28).
To determine the role of MSX2 in this process, we co-trans-
fected the pLTRLuc reporter vector together with expression
vectors for Tax, CREB2, PKA, and MSX2 as indicated on Fig. 4.
As expected, MSX2 represses Tax transactivation (Fig. 4A,
compare lanes 2 and 6). Co-transfection of bovine CREB2 par-
tially reverted MSX2 inhibition of Tax-transactivation (Fig. 4A,
compare lanes 2, 3, 6, and 7). In the presence of bovine CREB2
and PKA, MSX2 completely lost its ability to inhibit Tax trans-
activation (Fig. 4A, compare lanes 4 and 8). Taken together,
these data demonstrate that overexpression and activation of
CREB2 by PKA reverts MSX2 repressor function.
It has been shown that MSX2 suppresses transcription
through interaction with RAP74, the large subunit of TFIIF, and
FIG. 2. Co-localization between BLV Tax and MSX2 in HeLa
cells. HeLa cells were transfected with pSGTax (coding for BLV Tax),
and pcDNAMSX2-c-Myc (expressing MSX2-tagged by c-Myc), as indi-
cated. Twenty-four hours after transfection, cells were fixed, permeabi-
lized, and labeled with Tax and c-Myc-specific antibodies and Alexa-546
or FITC-conjugated secondary antiserum. Finally, labeled cells were
stained with TOPRO-3 and analyzed by confocal microscopy (Zeiss
LSM510 coupled with an Axiovert 200 microscope). The orange arrows
indicate differential localization of Tax in MSX2Tax double positive
cells whereas the yellow arrows depict Tax single positive cells.
TABLE II
MSX2 does not interfere with the Tax immortalizing function in vitro
Primary REF cells were transfected with expressing vectors for indi-
cated proteins and, as negative control, the empty vector pSG5. One-
half of the cells were stably selected and transformed foci counted. The
other half were injected into nude mice and tumor volumes calculated
as described under “Experimental Procedures.” The number of nude
mice and the range of their tumor volumes are indicated.
DNA Cell culture Nude mice
Myc 50 foci (7) 6/6 (5000–7000 mm3)
pSG5 0 6/6 (	150 mm3)
Tax 22 foci (5) 6/6 (900–3000 mm3)
MSX2 0 6/6 (	300 mm3)
Tax  MSX2 25 foci (4) 6/6 (400–900 mm3)
Interaction of MSX2 with Tax 29807
that RAP74 is able to counteract the MSX2-repression of the
osteocalcin promoter (33). To determine the role of RAP74 in
MSX2 repression of the LTR promoter activation, we co-trans-
fected pLTRLuc reporter vector together with expression vectors
for Tax, MSX2, and increasing amounts of RAP74. As shown in
Fig. 4B, RAP74 was able to reverse, in a dose-dependent manner,
the MSX2 repression of LTR transactivation (Fig. 4B, compare
lanes 7–10). To analyze the effects of RAP74 and Tax on MSX2
repression, we co-transfected the LTR reporter vector with ex-
pression vectors for RAP74, MSX2, and increasing amounts of
Tax. We then calculated the percentage of MSX2 inhibition of
LTR activity by comparing luciferase data from cell samples
overexpressing MSX2 to those from cells lacking MSX2. As
shown in Fig. 4C, MSX2 repression of LTR promoter activity
gradually decreased in the presence of increasing amounts of Tax
(Fig. 4C, compare lanes 1–5) and, as expected, the presence of
RAP74 also interfered with MSX2 inhibition of the LTR activa-
tion (Fig. 4C, lanes 6–10). Taken together, these data demon-
strate that overexpression of transcription factors CREB2 or
RAP74 and the presence of high doses of Tax can independently
interfere with MSX2 repressor function.
MSX2 Also Interacts with HTLV-1 Tax and Represses Its
Transactivation Activity—To test whether MSX2 also interacts
with HTLV-1 Tax, both proteins were synthesized separately in
rabbit reticulocyte lysates using plasmids pSGTax1 and
pcDNAMSX2-c-Myc in the presence of 35S-labeled methionine
and cysteine (Fig. 5A). Equal volumes (10 l) of each lysate
were incubated over 4 h, and the Tax1 protein immunoprecipi-
tated using either the Tax1 antibody or a control antiserum.
The immunoprecipitates were analyzed by SDS-PAGE and re-
vealed by Western blotting with anti-c-Myc antibody. As shown
in Fig. 5B, c-Myc-tagged MSX2 protein specifically co-immuno-
precipitated with Tax1.
To examine whether MSX2 could also interfere with tran-
scriptional activation of the HTLV-1 LTR promoter, we co-
transfected HeLa or Jurkat cells with expression vectors for
Tax1 (pCMVTax) and MSX2 (pSGMSX2) together with a
HTLV-1 LTR luciferase reporter construct. Twenty-four hours
post-transfection, the cells were harvested, and the luciferase
activities were measured in the lysates. It appeared that MSX2
represses HTLV Tax1 transactivation in a dose-dependent
manner (Fig. 5C).
Because BLV and HTLV-1 infect different cell types (i.e.
respectively, B- and T-lymphocytes), we next compared the
endogenous levels in a bovine B-lymphoblastoid cell line (BL3)
and in Jurkat T-cells. In both cell lines, the endogenous MSX2
levels were similar (lanes 1 and 3 of Fig. 6). In addition, the
amount of MSX2-cMyc generated by plasmid transfection com-
pared with the endogenous levels is about 2-fold higher in BL3
cells and 3-fold higher in Jurkat T cells (lanes 2 and 4, Fig. 6).
We conclude that the homeobox protein MSX2 targets both
BLV and HTLV-1 Tax oncoproteins and reduces their transac-
tivation activities.
FIG. 3.MSX2 inhibits Tax transacti-
vation. A, 1 g of BLVLTR-Luc reporter
plasmid, and, as indicated, different
amounts of expressing vectors for MSX2
and Tax (pSGMSX2 and pSGTax) were
transfected into HeLa cells. Luciferase ac-
tivities were determined 24 h post-trans-
fection. The data are the mean of relative
luciferase activities of three independent
experiments normalized to protein con-
centrations. Error bars represent S.D. B,
Western blot analysis of transfected cells
(30 l equivalent to one-fifth of lysates
corresponding to lanes 1–6 of A) using
anti-BLV Tax antibody, anti-Msx2 anti-
body, or anti-actin antiserum. C, 1 g of
CMV-Luc reporter plasmid and, as indi-
cated, different amounts of expressing
vector for MSX2 (pSGMSX2) were trans-
fected into HeLa cells. Luciferase activi-
ties were determined 24 h post-transfec-
tion. The data are the mean of relative
luciferase activities of three independent
experiments normalized to protein con-
centrations. Error bars represent S.D. D,
1 g of reporter plasmid BLVLTR-Luc,
and, as indicated, different amounts of
expressing vectors for MSX2, and Tax
were transfected into BL3 cells by the
TransIT-Jurkat procedure. Luciferase ac-
tivities were determined 24 h post-trans-
fection. The data are the means of relative
luciferase activities of three independent
experiments normalized to protein con-
centrations. Error bars represent S.D. E,
1 g of BLVLTR-Luc reporter plasmid,
and, as indicated, different expressing
vectors for MSX2 (pcDNAMSX2-c-Myc,
pcDNAMSX2C-c-Myc, pcDNAMSX2N-
c-Myc), MSX1 (pSGMSX1), and Tax (pS-
GTax) were transfected into HeLa cells.
Luciferase activities were determined
24 h post-transfection. The data are the
mean of relative luciferase activities of
three independent experiments normal-
ized to protein concentrations. Error bars
represent S.D.
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DISCUSSION
BLV and HTLV-1 are closely related retroviruses sharing
similar genomic organizations and affecting cells from the he-
matopoietic system. However, these two viruses infect different
cell types (CD4 and CD8 T-lymphocytes for HTLV-1 and B cells
for BLV) and are not subject to mutual cross-transmissions.
The induced diseases are also different: ATL (adult T-cell leu-
kemia) or TSP (tropical spastic paraparesis) for HTLV-1 and
EBL (enzootic bovine leukemia) for BLV. However, for both
viruses, the tax gene is thought to be a major actor in patho-
genesis, and the aim of this report is to unravel the metabolic
pathways involved in this process.
By means of the two-hybrid system, we identified MSX2 as a
cellular partner specifically interacting with BLV Tax. Several
FIG. 4. Transcription factors RAP74
and CREB2 interfere with the MSX2
repression of the LTR transactivation.
A, 1 g of a reporter plasmid pLTR-Luc
and different effector plasmids (pSGMSX2
for MSX2, pSGTax for BLV Tax, pS-
GCREB for bovine CREB2, and pPKA for
protein kinase A) were transfected into
HeLa cells. Luciferase activities were de-
termined 24 h post-transfection. The data
are the mean of relative Luciferase activi-
ties of three independent experiments nor-
malized to protein concentrations. Error
bars represent S.D. B, 1 g of a reporter
plasmid pLTR-Luc and, as indicated, in-
creasing amounts of RAP74-expressing
vector (pcDNARAP74-Flag) and two other
effector plasmids (pcDNAMSX2-c-Myc for
MSX2 and pSGTax for BLV Tax) were
transfected into HeLa cells. Luciferase ac-
tivities were determined 24 h post-trans-
fection. The data are the mean of relative
Luciferase activities of three independent
experiments normalized to protein concen-
trations. Error bars represent S.D. C, 1 g
of a reporter plasmid pLTR-Luc and, as
indicated, increasing amounts of Tax-ex-
pressing vector (pSGTax) and two other
effector plasmids (pcDNAMSX2-c-Myc and
pcDNARAP74-Flag) were transfected into
HeLa cells. Luciferase activities were de-
termined 24 h post-transfection. The lucif-
erase activities data were normalized to
protein concentrations and the percentage
of MSX2-inhibition of the LTR transactiva-
tion was calculated by comparing samples
in the presence or absence of MSX2. The
data are the mean of the percentage of
MSX2 inhibition of the LTR transactiva-
tion of three independent experiments. Er-
ror bars represent S.D.
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lines of evidence support the specificity of interaction between
Tax and MSX2. First, when the expression vectors for both
partners were isolated and re-introduced into yeast, the result-
ing cells yielded high levels of -galactosidase activity. It
should be mentioned here that a weak signal was measured in
yeast containing only the bait vector (Table I, pBDTax), further
supporting the existence of an activation domain within Tax, as
described previously (39). Other evidence for specificity for
BLV Tax and MSX2 interaction have been obtained by two
other independent techniques: GST pull-down and co-immuno-
precipitations experiments (Fig. 1). Furthermore, we showed
that the N-terminal residues 1–79 of MSX2 are required for
binding, whereas the C-terminal residues 201–267 of MSX2 do
not play a critical role in the interaction. The MSX gene family
comprises three members (MSX1, MSX2, and MSX3). MSX1
and MSX2 are often co-expressed in tissues and share 98% of
primary structure identity in their homeodomain, 62% identity
in their C-terminal regions, and 51% identity in their N-termi-
nal regions. We found that MSX1 did not bind Tax, further
confirming the specificity of Tax/MSX2 interaction. Similar
approaches extended these observations to HTLV Tax (Fig. 5).
In vivo, BLV and HTLV infect different cell types (B and T
lymphocytes, respectively). In this report, we showed that
MSX2 affects both Tax proteins in the same way and that the
MSX2 endogenous expression levels are comparable in B and T
cell lines (Fig. 6). These data suggest that mechanisms involv-
ing similar cellular pathways are shared by the BLV and HTLV
viruses.
MSX2 is a general negative regulator of gene expression
known to interact with some components of the basal transcrip-
tion machinery (33). Direct interaction with DNA is apparently
not required forMSX2 suppressor function.MSX2 rather inhibits
transcription via protein-protein interactions with components of
the basal transcription machinery such as TFIIF (RAP74 and
RAP30) (33). MSX2 belongs to a family of homeobox proteins,
which have been implicated in epithelial-mesenchymal interac-
tions during embryogenesis in various body tissues and their
expression is often associated with high cellular growth potential
(41–45). The MSX2 homeodomain protein has also been involved
in the transcriptional mechanisms that regulate osteoblast pro-
liferation, differentiation, and gene expression. MSX2 suppresses
the osteocalcin promoter and induces craniosynostosis syndrome,
characterized by precocious differentiation of calvarial osteopro-
genitor (33, 46, 47). Most interestingly, overexpression of MSX2
was found in a large proportion of carcinoma cell lines and in
several tumors (47). In addition, overexpression of antisense
MSX2 cDNA interferes with cell transformation induced by the
-Ki-ras oncogene, suggesting its possible role in carcinogenesis
(32).
Here, we have shown that the interaction between Tax and
MSX2 results in an inhibition of LTR-directed gene expression
in fibroblasts and lymphoid cell lines. Comparatively, tran-
scription directed by the LTR was apparently more affected
than that of other promoters like CMV (Fig. 3), SV40, and TRE
(data not shown), suggesting a possible specificity of inhibition.
Under these conditions, viral expression would thus be silenced
without affecting the transcription of other cellular genes. We
speculate about a possible mechanism allowing silencing of
viral gene expression during activation and replication of the
FIG. 5. MSX2 interacts with HTLV-1 Tax and represses its
transactivation activity. A, MSX2 tagged by c-Myc and Tax1 pro-
teins were separately synthesized using rabbit reticulocyte lysates in
the presence of 35S-labeled methionine and cysteine. Five microliters of
the programmed lysates were then electrophoresed in a 12.5% SDS-
PAGE gel, dried, and exposed to an x-ray film. The empty vector
pcDNA3.1 was used as a negative control. B, 10 l of each lysate
containing in vitro translated Tax1 and MSX2-c-Myc proteins were
mixed in 500 l of NET buffer and incubated for 4 h at 4 °C. The Tax1
protein was then immunoprecipitated using specific antibody (Tax1)
or a control antiserum (Control IgG). The immunoprecipitates were
analyzed by SDS-PAGE, transferred onto a nylon membrane and re-
vealed with anti-c-Myc antibody. C, 1 g of reporter plasmid
HTLV1LTR-Luc, and, as indicated, different amounts of expressing
vectors for MSX2, and Tax1 were transfected into HeLa or Jurkat cells
by the GeneJammer or TransIT-Jurkat procedures, respectively. Lucif-
erase activities were determined 24 h post-transfection. The data are
the mean of relative luciferase activities of three independent experi-
ments normalized to protein concentrations. Error bars represent S.D.
FIG. 6. Expression of MSX2 in BL3 and Jurkat cell lines. BL3
and Jurkat cell lysates were separated by SDS-PAGE and subjected to
Western blot analysis using anti-Msx2 antibody (lanes 1 and 3, respec-
tively). Lysates from BL3 and Jurkat cell lines transfected with 1 g of
pcDNAMSX2-c-Myc were analyzed in parallel on lanes 2 and 4, respec-
tively. Arrows indicate transfected (Msx2-cMyc) and endogenous Msx2
proteins. The protein band intensities were measured using Scion
Image tools (www.scioncorp.com).
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host cell. Interestingly, MSX2 repression could be overcome by
overexpression of CREB2 and the catalytic subunit of protein
kinase A (Fig. 4A) In this context, several models are conceiv-
able: (i) the CREB/PKA pathway activates a gene that inhibits
MSX2, (ii) the CREB/Tax complex displaces MSX2 from the
preinitiation complex, (iii) CREB and MSX2 have similar or
overlapping recognition sites on Tax resulting in mutual exclu-
sion of both proteins. In any case, we have shown that activa-
tion via the CREB/PKA pathway reverts MSX2 repression of
Tax transactivation. It has been shown that RAP74 binds di-
rectly to the core suppressor domain of MSX2 and reverses
inhibition of the osteocalcin promoter activity (33). Here, we
extended these observations to the BLV LTR promoter activa-
tion by providing evidences that RAP74 can also interfere with
MSX2-repression of BLV LTR-directed transactivation (Fig. 4,
B and C). However, RAP74 and Tax require two different
regions of MSX2 for binding (residues 132–148 and 1–79, re-
spectively) and Tax does not influence RAP74/MSX2 interac-
tion (Supplemental Fig. 1). Another major point of this report
concerns the immortalizing potential of BLV Tax. We have
indeed shown that MSX2 does not abolish the ability of BLV
Tax to transform REF cells (Table II). It thus appears that
MSX2 represses Tax-dependent transactivation but still per-
mits cell transformation indicating that both functions of Tax
are differently modulated by MSX2. It should be mentioned
here that separable domains within the BLV Tax protein me-
diate transactivation and transformation (16). Indeed muta-
tions in the zinc finger structure abrogate the capacity of Tax to
activate viral expression without concomitant loss of immortal-
ization (14). On the other hand, phosphoserines 106 and 293 of
BLV Tax are required for in vitro transformation but not for
transactivation (16). Dissociation of these two activities of Tax
might be a major process which allows cell immortalization in
the absence of viral structural gene expression. The Tax/MSX2
interplay may therefore play an important role in viral silenc-
ing and persistence as well as oncogenesis in vivo.
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